SK bioscience Co.,Ltd. (KRX:302440)
South Korea
· Delayed Price · Currency is KRW 51,300
+6,250 (13.87%)
At close: Jun 20, 2025, 3:30 PM KST
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 4.02 trillion as of June 20, 2025. Its market cap has decreased by -9.93% in one year.
Market Cap
4.02T
Enterprise Value
3.47T
Revenue
399.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
51,300.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 4.02T, a decrease of -68.90%. That is a compound annual growth rate of -23.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 4,020.34B | 1.81% |
| Dec 30, 2024 | 3,948.70B | -28.57% |
| Dec 28, 2023 | 5,528.45B | -2.04% |
| Dec 29, 2022 | 5,643.63B | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.10T |
| Celltrion | 35.43T |
| ALTEOGEN | 20.68T |
| Yuhan | 7,519.86B |
| SK Biopharmaceuticals | 7,063.86B |
| HLB Co., Ltd. | 6,978.05B |
| PharmaResearch | 4,696.12B |
| Peptron | 4,652.48B |